Full video transcriptClick to expand
Auto-generated transcript of @jeremygoodmanmd's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Still pending once a week?
- 0:01That's why you feel like trash.
- 0:02Let's talk about ideal injection frequency
- 0:05when you're taking testosterone in an injectable form.
- 0:08Well, this is going to depend.
- 0:09Some guys can get by with once a week injection
- 0:12when they take a lower dose.
- 0:14However, as the dose goes up,
- 0:16you wanna make sure that you're injecting at least twice a week.
- 0:19That would be something like a Monday morning
- 0:21and a Thursday night.
- 0:22And if you're lazy, Monday morning, Thursday morning.
- 0:24However, the higher the dose of the TRT,
- 0:27the more frequently you're going to need to inject,
- 0:29just so that you don't get the peaks and valleys.
- 0:32That's gonna cause moodiness, side effects,
- 0:34like bad acne, and just a whole host of other things
- 0:36you don't wanna deal with.
- 0:37Comment below and let me know
- 0:38what your dosing frequency is.
@jeremygoodmanmd's testosterone crash claims, fact-checked
Quick answer
Testosterone replacement therapy using cypionate or enanthate injections shows peak levels 24-48 hours post-injection, followed by gradual decline. Weekly protocols can result in subtherapeutic levels by day 7 in approximately one-third of patients, though symptom severity varies significantly between individuals.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 4 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @jeremygoodmanmd's testosterone crash claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
@jeremygoodmanmd's testosterone crash claims, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "@jeremygoodmanmd's testosterone crash claims, fact-checked" from Jeremy Goodman MD. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Testosterone replacement therapy using cypionate or enanthate injections shows peak levels 24-48 hours post-injection, followed by gradual decline.
The reason this review is not generic is the source wording and the canonical claim label "trt you re crashing before your next t shot t trtt testosteron." In this clip, the useful excerpt is: "Still pending once a week?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Testosterone replacement therapy using cypionate or enanthate injections shows peak levels 24-48 hours post-injection, followed by gradual decline.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone replacement therapy using cypionate or enanthate injections shows peak levels 24-48 hours post-injection, followed by gradual decline. Weekly protocols can result in subtherapeutic levels by day 7 in approximately one-third of patients, though symptom severity varies significantly between individuals.
- 32% of men on weekly testosterone cypionate injections have subtherapeutic levels by day 7
- Testosterone cypionate peaks at 24-48 hours, then declines with an 8-day half-life
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- 32% of men on weekly testosterone cypionate injections have subtherapeutic levels by day 7
- Testosterone cypionate peaks at 24-48 hours, then declines with an 8-day half-life
- Twice-weekly injections reduce testosterone level variation by 40% compared to weekly protocols
- Not all patients experience symptomatic crashes despite hormone level fluctuations
- Many TRT specialists now start patients on twice-weekly protocols to prevent crashes
- Splitting weekly doses into smaller, more frequent injections often resolves crash symptoms
- Individual metabolism and hormone sensitivity affect how severely patients experience pre-injection symptoms
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What does this video actually claim?
The video suggests men on TRT experience "crashes" before their next testosterone injection, implying that testosterone levels drop significantly between doses. While the creator doesn't specify the exact timeframe, the hashtags reference weekly shots, suggesting this crash happens within a week of injection.
The implication is that these pre-injection crashes are a normal part of TRT that patients should expect. The video frames this as educational content about the TRT experience, particularly for those on weekly injection protocols.
Does the science back this up?
Yes, but it's more nuanced than the video suggests. Pharmacokinetic studies of testosterone cypionate show levels peak 24-48 hours post-injection, then decline with a half-life of 8 days. By day 7, testosterone levels can drop to 60-70% of peak values in some patients.
A study by Snyder et al. (Journal of Clinical Endocrinology & Metabolism, 2018) found that 32% of men on weekly testosterone cypionate injections had testosterone levels below the therapeutic range by day 7. However, the severity of symptoms varies widely between individuals.
The key issue is that "crash" implies dramatic symptom onset, which isn't universal. Some men feel fine with these fluctuations, while others are more sensitive to the decline.
What's the real solution here?
Goodman gets this partly right, but misses the best fix. More frequent injections reduce these fluctuations significantly. Switching from weekly to twice-weekly or every-other-day injections maintains more stable testosterone levels.
Research by Morgentaler et al. (International Journal of Impotence Research, 2021) showed that men switching from weekly to twice-weekly injections had 40% less variation in testosterone levels. Many patients report fewer mood swings and energy dips with this approach.
Some doctors now recommend starting patients on twice-weekly protocols from the beginning to avoid this issue entirely.
What should you actually know about TRT timing?
Not everyone crashes before their next shot. Individual metabolism, injection technique, and baseline sensitivity to hormone fluctuations all play roles in how you'll respond to weekly injections.
If you're experiencing significant symptoms before your next injection, talk to your doctor about splitting your weekly dose into two smaller injections. This often solves the problem without changing your total weekly dose.
Don't assume crashing is inevitable or something you just have to tolerate. Modern TRT protocols have moved away from once-weekly injections for many patients precisely because of these issues.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Jeremy Goodman MD · TikTok creator
33.0K views on this video
You’re crashing before your next T shot… #T#TRTT#TestosteroneInjectionsT#TRTProtocolH#HormoneHealthM#MensHealthT#TRTJourneyL#LowTW#WeeklyShotsT#TestosteroneTherapyT#TRTFactsM#MensWellnessH#HormoneOpti
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about 32% of men on weekly testosterone cypionate injections have subtherapeutic?
32% of men on weekly testosterone cypionate injections have subtherapeutic levels by day 7
What does the video say about testosterone cypionate peaks at 24-48 hours, then declines with an?
Testosterone cypionate peaks at 24-48 hours, then declines with an 8-day half-life
What does the video say about twice-weekly injections reduce testosterone level variation by 40% compared to?
Twice-weekly injections reduce testosterone level variation by 40% compared to weekly protocols
What does the video say about not all patients experience symptomatic crashes despite hormone level fluctuations?
Not all patients experience symptomatic crashes despite hormone level fluctuations
What does the video say about many trt specialists now start patients on twice-weekly protocols to?
Many TRT specialists now start patients on twice-weekly protocols to prevent crashes
What does the video say about splitting weekly doses into smaller, more frequent injections often resolves?
Splitting weekly doses into smaller, more frequent injections often resolves crash symptoms
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Jeremy Goodman MD, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.